- Wealth
- ₹1,800 Cr
- Company
- Ajanta Pharma
YM
Yogesh Mannalal Agrawal
About Yogesh Mannalal Agrawal
Data last updated:
Yogesh Mannalal Agrawal is a Managing Director at Ajanta Pharma Limited (since 2008), Director at Gabs Investments Private Limited (since 2017) and Director at Averon Private Limited (since 2025), and holds 1 more current directorship. The companies operate in Pharma, Financial Services and Energy and Power. The 2 current companies with reported revenue have a combined latest revenue of ₹4,778 Cr; the largest is Ajanta Pharma Limited at ₹4,743 Cr (FY 2025). Earlier, Yogesh Mannalal Agrawal was a Director at Riteaid Finance Private Limited (2017–2018) and Director at Swadesh Capital Private Limited (2017–2018) and 5 more.
Yogesh Mannalal Agrawal was among India's richest people in 2019 at #484.
Recognitions & Rankings
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 01 Apr 2008 | 1979 | ₹4,743 Cr (FY 2025) | Active | |
| Director | 01 Mar 2017 | 1995 | ₹35.46 Cr (FY 2025) | Active | |
| Director | 15 Dec 2025 | 2025 | Active | ||
| Designated Partner | 05 Dec 2025 | 2025 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 24 Oct 2017 | 2017 | ₹22,510 (FY 2022) | Under Process Of Striking Off | |
| Director | 17 Oct 2017 | 2017 | ₹16,986 (FY 2023) | Strike Off | |
| Director | 12 Jun 2012 | 2012 | Active | ||
| Designated Partner | 20 Dec 2017 | 2017 | Active | ||
| Designated Partner | 01 Jun 2016 | 2016 | ₹11.2 Lakh (FY 2019) | Converted To Cmp And Dissolved | |
| Designated Partner | 03 Nov 2015 | 2015 | ₹15.31 Cr (FY 2025) | Active | |
| Designated Partner | 21 Dec 2017 | 2017 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Yogesh Mannalal Agrawal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Arvind Kanhaiyalal Agrawal | Ajanta Pharma Limited | Cfo | |
| David Paul Rasquinha | 01172654 | Ajanta Pharma Limited | Director |
| Gaurang Chinubhai Shah | Ajanta Pharma Limited | Company Secretary | |
| Madhusudan Bhagwandas Agrawal | 00073872 | Ajanta Pharma Limited | Whole-Time Director |
| Mannalal Bhagwandas Agrawal | 00073828 | Ajanta Pharma Limited | Director |
| Medha Vinay Joshi | 00328174 | Ajanta Pharma Limited | Director |
| Rajesh Mannalal Agrawal | 00302467 | Ajanta Pharma Limited , Gabs Investments Private Limited | Whole-Time Director |
| Rajesh Shashikant Dalal | 03504969 | Ajanta Pharma Limited | Director |
| Simi Manohar Lal Thapar | 10470498 | Ajanta Pharma Limited | Director |
| Aayush Madhusudan Agrawal | 03129764 | Gabs Investments Private Limited | Director |
| Ravi Purushottam Agrawal | 00302243 | Gabs Investments Private Limited | Director |
| Manisha Yogesh Agrawal | 00075762 | Averon Private Limited , Valenta Enterprises Llp | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Yogesh Mannalal Agrawal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Yogesh Mannalal Agrawal
Yogesh Mannalal Agrawal currently holds 4 directorships: Ajanta Pharma Limited (Managing Director, since 01 Apr 2008, revenue ₹4,743 Cr (FY 2025)); Gabs Investments Private Limited (Director, since 01 Mar 2017, revenue ₹35.46 Cr (FY 2025)); Averon Private Limited (Director, since 15 Dec 2025); Valenta Enterprises Llp (Designated Partner, since 05 Dec 2025).
Yogesh Mannalal Agrawal was first appointed on 01 Apr 2008 as Managing Director at Ajanta Pharma Limited. The most recent appointment on record is 15 Dec 2025 at Averon Private Limited.
The 2 current companies of Yogesh Mannalal Agrawal that report revenue have a combined latest revenue of ₹4,778 Cr: Ajanta Pharma Limited ₹4,743 Cr (FY 2025); Gabs Investments Private Limited ₹35.46 Cr (FY 2025).
Yogesh Mannalal Agrawal held 7 earlier board appointments: Riteaid Finance Private Limited (Director, 24 Oct 2017 to 01 Feb 2018); Swadesh Capital Private Limited (Director, 17 Oct 2017 to 01 Feb 2018); Inspira Martifer Solar Limited (Director, 12 Jun 2012 to 10 Oct 2018); Riteaid Enterprises Llp (Designated Partner, 20 Dec 2017 to 24 Oct 2019); Gencrest Llp (Designated Partner, 01 Jun 2016 to 31 Mar 2017); and 2 more.
The current boards of Yogesh Mannalal Agrawal's companies include Arvind Kanhaiyalal Agrawal (Ajanta Pharma Limited), David Paul Rasquinha (Ajanta Pharma Limited), Gaurang Chinubhai Shah (Ajanta Pharma Limited), Madhusudan Bhagwandas Agrawal (Ajanta Pharma Limited), Mannalal Bhagwandas Agrawal (Ajanta Pharma Limited), Medha Vinay Joshi (Ajanta Pharma Limited), among others.